Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke

BK. Menon, FS. Al-Ajlan, M. Najm, J. Puig, M. Castellanos, D. Dowlatshahi, A. Calleja, SI. Sohn, SH. Ahn, A. Poppe, R. Mikulik, N. Asdaghi, TS. Field, A. Jin, T. Asil, JM. Boulanger, EE. Smith, SB. Coutts, PA. Barber, S. Bal, S. Subramanian, S....

. 2018 ; 320 (10) : 1017-1026.

Language English Country United States

Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc18032980

Importance: Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. Objective: To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. Design, Setting, and Participants: Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). Exposures: Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. Main Outcomes and Measures: Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). Results: Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3% (157/575) overall, including in 30.4% (143/470) of patients who received intravenous alteplase and 13.3% (14/105) who did not (difference, 17.1% [95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). Conclusions and Relevance: In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18032980
003      
CZ-PrNML
005      
20181026120037.0
007      
ta
008      
181008s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1001/jama.2018.12498 $2 doi
035    __
$a (PubMed)30208455
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Menon, Bijoy K $u University of Calgary, Calgary, Alberta, Canada.
245    10
$a Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke / $c BK. Menon, FS. Al-Ajlan, M. Najm, J. Puig, M. Castellanos, D. Dowlatshahi, A. Calleja, SI. Sohn, SH. Ahn, A. Poppe, R. Mikulik, N. Asdaghi, TS. Field, A. Jin, T. Asil, JM. Boulanger, EE. Smith, SB. Coutts, PA. Barber, S. Bal, S. Subramanian, S. Mishra, A. Trivedi, S. Dey, M. Eesa, T. Sajobi, M. Goyal, MD. Hill, AM. Demchuk, . ,
520    9_
$a Importance: Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. Objective: To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. Design, Setting, and Participants: Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). Exposures: Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. Main Outcomes and Measures: Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). Results: Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3% (157/575) overall, including in 30.4% (143/470) of patients who received intravenous alteplase and 13.3% (14/105) who did not (difference, 17.1% [95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). Conclusions and Relevance: In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.
650    _2
$a intravenózní podání $7 D061605
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ischemie mozku $x farmakoterapie $x chirurgie $7 D002545
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a CT angiografie $7 D000072226
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrinolytika $x terapeutické užití $7 D005343
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a cévní mozková příhoda $x diagnostické zobrazování $x farmakoterapie $x chirurgie $7 D020521
650    12
$a trombektomie $7 D017131
650    _2
$a tkáňový aktivátor plazminogenu $x terapeutické užití $7 D010959
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Al-Ajlan, Fahad S $u King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
700    1_
$a Najm, Mohamed $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Puig, Josep $u IDI-IDIBGI, Dr Josep Trueta University Hospital, Girona, Spain.
700    1_
$a Castellanos, Mar $u IDI-IDIBGI, Dr Josep Trueta University Hospital, Girona, Spain.
700    1_
$a Dowlatshahi, Dar $u University of Ottawa, Ottawa, Ontario, Canada.
700    1_
$a Calleja, Ana $u Universidad de Valladolid, Valladolid, Spain.
700    1_
$a Sohn, Sung-Il $u Keimyung University, Daegu, Republic of Korea.
700    1_
$a Ahn, Seong H $u Keimyung University, Daegu, Republic of Korea. Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
700    1_
$a Poppe, Alex $u University of Montreal, Montreal, Québec, Canada.
700    1_
$a Mikulik, Robert $u International Clinical Research Center, Department of Neurology, St Ann's University Hospital, Masaryk University, Brno, Czech Republic.
700    1_
$a Asdaghi, Negar $u University of Miami, Miami, Florida.
700    1_
$a Field, Thalia S $u University of British Columbia, Vancouver, British Columbia, Canada.
700    1_
$a Jin, Albert $u Queen's University Kingston, Ontario, Canada.
700    1_
$a Asil, Talip $u Bezmialem Vakif Univesitesi Noroloji, Istanbul, Turkey.
700    1_
$a Boulanger, Jean-Martin $u Greenfield Park, Québec, Canada.
700    1_
$a Smith, Eric E $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Coutts, Shelagh B $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Barber, Phil A $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Bal, Simerpreet $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Subramanian, Suresh $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Mishra, Sachin $u Gold Coast University Hospital, Gold Coast, Australia.
700    1_
$a Trivedi, Anurag $u University of Manitoba, Winnipeg, Manitoba, Canada.
700    1_
$a Dey, Sadanand $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Eesa, Muneer $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Sajobi, Tolulope $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Goyal, Mayank $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Hill, Michael D $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Demchuk, Andrew M $u University of Calgary, Calgary, Alberta, Canada.
700    1_
$a ,
773    0_
$w MED00002973 $t JAMA $x 1538-3598 $g Roč. 320, č. 10 (2018), s. 1017-1026
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30208455 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181026120548 $b ABA008
999    __
$a ok $b bmc $g 1339332 $s 1029974
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 320 $c 10 $d 1017-1026 $i 1538-3598 $m JAMA (Chicago, Ill.) $n JAMA $x MED00002973
LZP    __
$a Pubmed-20181008
Back

Find record

Citation metrics

Archiving options